Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S B (OP: NONOF )

106.40 -4.20 (-3.80%)
Streaming Delayed Price Updated: 12:15 PM EST, Nov 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novo Nordisk A/S B

Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
The greater weight loss in women did not result in significantly better improvements in heart failure symptoms. 
Via Benzinga
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide. 
Via Benzinga
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty. 
Via InvestorPlace
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug. 
Via Benzinga
7 Mutual Funds That Will Outperform in Any Market
While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds. 
Via InvestorPlace
Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
Via Benzinga
Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
This initiative has been touted as the biggest investment in the health sector ever made during Macron's tenure. 
Via Benzinga
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
Via Benzinga
Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
Via Benzinga
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors. 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.